Chiara Ciccarese
@ciccarese_c
MD, PhD. Researcher at Università Cattolica del Sacro Cuore and Oncologist at Fondazione Policlinico Gemelli IRCCS Rome, Italy
ID: 1255501153615429639
29-04-2020 14:16:25
69 Tweet
160 Followers
55 Following
Day 3 of #ESMO24 and a stellar presentation by Chiara Ciccarese on the preliminary results of the TACITO trial, exploring fecal microbiota transplantation (#FMT) in #mRCC. FMT + pembrolizumab + axitinib showed a significant increase in 1-year PFS vs. placebo, highlighting the
One of the most intriguing implications of the TACITO study presented today by Chiara Ciccarese at #ESMO2024 is that responders pts to immunotherapy can help other pts to achieve response and longer control of metastic kidney cancer. Kidney Cancer IKCC Kidney Cancer KidneyCAN associazionepalinuro
What a stellar team! 🌟 Part of the Oncology Unit of Fondazione Policlinico Gemelli IRCCS in Rome 🇮🇹 at #ESMO2024. We are leaded by a visionary boss and mentor Prof Giampaolo Tortora. Università Cattolica Emilio Bria Chiara Ciccarese Antonella Palazzo Lisa Salvatore Armando Orlandi and many, many other..
❗️❗️ One more piece of Aron Project published at International Journal of Cancer. RWE of mRCC with sarcomatoid features. ⬇️OS for sRCC: 26.8m vs 35.3m ⭕️ no difference across IO combos in this population. Congrats Chiara Ciccarese Francesco Massari Ray Manneh Kopp onlinelibrary.wiley.com/doi/10.1002/ij…
After years and years of inconclusive trials in adjuvant tx of MIBC and few evidence in adjuvant therapy, Tom Powles and NIAGARA study team show us the way to increas OS in bladder cancer and save lives! OncoAlert GU Oncology Now OncoDaily Petros Grivas
Fecal microbiota transplantation vs PBO in pts receiving pembrolizumab + axitinib for metastatic #RCC. Preliminary results of the randomized phase 2 #TACITO trial. Presentation by Chiara Ciccarese. #ESMO24 written coverage by Julian Chavarriaga > bit.ly/3Xpim01 ESMO - Eur. Oncology
Always a pleasure to hear the point of view of Christopher Sweeney, MBBS about #ProstateCancer at ESMO - Eur. Oncology . Wonder if biomarker-based treatment choice for mPC would be the real next future
Another adventure completed with these amazing colleagues. Friendship, mutual support, and generosity always shine through! Roberto Iacovelli Chiara Ciccarese Sjoukje Lubberts Pablo A. Ballesteros @ Cristina Boixareu Daniele Raggi #ESMO24 Massimo Di Maio EORTC
Faecal microbiota transplantation increases activity of immunotherapy in mRCC - ecancer ecancer.org/en/video/12034… 📢📢📢about our study of FMT OncoAlert ESMO - Eur. Oncology Roberto Iacovelli Gianluca Ianiro Università Cattolica
🚨 Don’t miss the European School of Urology (EAU ESU) #Webinar by YAU RCC on #October #1st! 🕕 10 PM IST (18:30 CEST) 🔹 Topics: Robot-assisted #partial #nephrectomy, #SBRT, and #adjuvant #immunotherapy. 🔹 Q&A with all YAU RCC members! 🔗 Register now: [webinars.uroweb.org/EAU/webinars/1…] 👇 See the full
![🚨 Don’t miss the <a href="/UrowebESU/">European School of Urology (EAU ESU)</a> #Webinar by YAU RCC on #October #1st!
🕕 10 PM IST (18:30 CEST)
🔹 Topics: Robot-assisted #partial #nephrectomy, #SBRT, and #adjuvant #immunotherapy.
🔹 Q&A with all YAU RCC members!
🔗 Register now: [webinars.uroweb.org/EAU/webinars/1…]
👇 See the full](https://pbs.twimg.com/media/GYdgLyaaMAA3J16.jpg "EAU-YAU Renal Cancer Working Group (@eauyau_renalca) on Twitter photo 🚨 Don’t miss the <a href=\"/UrowebESU/\">European School of Urology (EAU ESU)</a> #Webinar by YAU RCC on #October #1st!
🕕 10 PM IST (18:30 CEST)
🔹 Topics: Robot-assisted #partial #nephrectomy, #SBRT, and #adjuvant #immunotherapy.
🔹 Q&A with all YAU RCC members!
🔗 Register now: [webinars.uroweb.org/EAU/webinars/1…]
👇 See the full")
I’m always fascinated and enriched by Sumanta K. Pal, MD, FASCO presentations. Thank you for the inspiration and sharing your incredible insights! #IUCS24 #oncoalert OncoAlert Giuseppe Banna OncoDaily Sumanta K. Pal, MD, FASCO an exceptional and unique mentor Nazli Dizman Roberto Iacovelli Chiara Ciccarese Hedyeh Ebrahimi
Fecal Microbiota Transplantation Boosts Response to Pembrolizumab Plus Axitinib in mRCC ESMO - Eur. Oncology Chiara Ciccarese #ESMO24 #kcsm #oncology #MedTwitter onclive.com/view/fecal-mic…
When you wouldn’t be anywhere else than where you are.Listening and learning from the most important Italian leaders of #RCC Roberto Iacovelli Camillo Porta fabio calabrò Francesco Massari Sebastiano Buti sergio.bracarda Luigi Formisano Marco Maruzzo Btw all but one love my boots!Guess who
La ricerca è il motore del futuro, contro questa malattia incerta e ineluttabile. Che immensa emozione oggi al Quirinale con il mio mentore Roberto Iacovelli per i giorni della ricerca di Fondazione AIRC per la ricerca sul cancro. Università Cattolica OncoAlert
Only standing room at #AIOM24 GU cancers session. Outstanding presentations & debates about hot topics in prostate, urothelial, and renal cancer. Proud to be within the scientific committee and thanks to Andrea Necchi Chiara Ciccarese Matteo Bauckneht Camillo Porta Giuseppe Procopio AIOM
I am so proud of these two fellows of mine at Università Cattolica who received the ASCO merit award at #GU25. 😍 Tutorship meaining is to improve young careers, allowing new experiences and sharing knowledge. OncoAlert ASCO OncoDaily AIOM Chiara Ciccarese Emilio Bria
This morning I have found this on my desk... I am so proud of this achievement! 😁 Thanks 🙏 to all investigators & European Urology for supporting Academic Research in GU cancers. Stay tuned 🛜 for other news from TIDE-A trial! European Association of Urology (EAU) UroFocus OncoAlert OncoDaily GU Oncology Now
